Résultats de la recherche - 226 results
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksAbstract
Degosserie, Jonathan; Denis, Olivier; Huang, Te-Din; Obbels, Dagmar; Valgaeren, Hanne; Frans, Johan; Smismans, Annick; Claus, Paul-Emile; Veltman, Denise; Goegebuer, Truus; Lemmens, Ann; Van den Poel, Bea; De ...
Bulletin acute luchtweginfecties week 48-2024- Gepubliceerd op 04.12.2024
Sarah Denayer; Anna Parys; François Dufrasne; Sven Hanoteaux; Robrecht De Schreye; S Moreels; Laura Debouverie; Mélanie Nahimana; Natalia Bustos Sierra; Catharina Vernemmen; Serge Nganda; Milena Callies; ...
Bulletin infections respiratoires aiguës semaine 48-2024- Publié 04/12/24
Lisa Hermans; Marjorie Fonnesu; Simon Couvreur; Veronik Hutse; Raphael Janssens Source: Sciensano, Brussels, p.48 (2024) URL: https://www.sciensano.be/fr/sujets-sante/influenza/chiffres Keywords: CNR ...
Epidemiologische surveillance van rabiës- 2023
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Inne Nauwelaers; Sanne Terryn Source: Sciensano, Brussels, Belgium, p.3 (2024) Accession Number: Keywords: ...
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Popescu, Corneliu-Petru; Majauskaite, Fausta; Tolksdorf, Kristin; Gomez, Verónica; Domegan, Lisa; Horváth, Judit Krisztina; Castilla, Jesús; García, Miriam; Demuyser, Thomas; Borg, Maria-Louise; Tabain, ...
Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.
concentration was significantly lower in the PCV13 +HepA than the HepA group: 34.47 mIU/mL (95% CI: 26.42-44.97 mIU/mL) versus 72.94 mIU/mL (95% CI: 55.01-96.72 mIU/mL), p < 0.001. Anti- HAV ≥10 mIU/mL ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Patricia CJL; Gomez, Verónica; Lesieur, Zineb; Barbezange, Cyril; van Nedervelde, Els; Borg, Maria-Louise; Castilla, Jesús; Lazar, Mihaela; O’Donnell, Joan; Jonikaite, Indrė; Demlová, Regina; Amerali, ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
CJL; Lazar, Mihaela; Demlová, Regina; Wirtz, Gil; Amerali, Marina; Dürrwald, Ralf; Kunstár, Mihály Pál; Kissling, Esther; Bacci, Sabrina; Valenciano, Marta; I-MOVE-COVID-19 hospital study team; VEBIS ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Patricia CJL; Gomez, Verónica; Lesieur, Zineb; Barbezange, Cyril; van Nedervelde, Els; Borg, Maria-Louise; Castilla, Jesús; Lazar, Mihaela; O'Donnell, Joan; Jonikaite, Indrė; Demlová, Regina; Amerali, ...
Surveillance des infections à influenza. Rapport épidémiologique saison 2019-2020
Vermeulen; B. Vos; Cyril Barbezange; F. Dufrasne; Sarah Denayer; Isabelle Thomas Source: Sciensano, Bruxelles, Belgique, p.32 (2023) Accession Number: D/2022.14.440/44 Keywords: INFLUENZA Abstract: La saison ...